img

Global Retinal Biologics Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Retinal Biologics Market Insights, Forecast to 2034

Many retinal biologics have been approved by the Food and Drug Administration (FDA), the European Medicine Agency (EMA) and the China Food and Drug Administration (CFDA) for the treatment of retinal diseases. Advancements in technologies and new mechanism of action for different biologics to treat retinal diseases are anticipated to boost the retinal biologics market.
Market Analysis and InsightsGlobal Retinal Biologics Market
Global Retinal Biologics market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Retinal Biologics industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Retinal Biologics key companies include Spark Therapeutics, Inc, F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc, AbbVie Inc, Johnson & Johnson Services, Inc and Amgen Inc, etc. Spark Therapeutics, Inc, F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Retinal Biologics were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Retinal Biologics market and estimated to attract more attentions from industry insiders and investors.
Retinal Biologics can be divided into Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema and Uveitis, etc. Macular Degeneration is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Retinal Biologics is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Retinal Biologics industry development. In 2022, global % revenue of Retinal Biologics went into Hospitals filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Retinal Biologics market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Retinal Biologics market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Spark Therapeutics, Inc
F. Hoffmann-La Roche Ltd
Regeneron Pharmaceuticals, Inc
AbbVie Inc
Johnson & Johnson Services, Inc
Amgen Inc
Segment by Type
Macular Degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Uveitis
Others

Segment by Application


Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Retinal Biologics introduction, etc. Retinal Biologics Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Retinal Biologics
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Macular Degeneration
1.2.3 Diabetic Retinopathy
1.2.4 Diabetic Macular Edema
1.2.5 Uveitis
1.2.6 Others
1.3 Market by Application
1.3.1 Global Retinal Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Retinal Biologics Market Perspective (2018-2033)
2.2 Global Retinal Biologics Growth Trends by Region
2.2.1 Retinal Biologics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Retinal Biologics Historic Market Size by Region (2018-2023)
2.2.3 Retinal Biologics Forecasted Market Size by Region (2024-2033)
2.3 Retinal Biologics Market Dynamics
2.3.1 Retinal Biologics Industry Trends
2.3.2 Retinal Biologics Market Drivers
2.3.3 Retinal Biologics Market Challenges
2.3.4 Retinal Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Retinal Biologics by Players
3.1.1 Global Retinal Biologics Revenue by Players (2018-2023)
3.1.2 Global Retinal Biologics Revenue Market Share by Players (2018-2023)
3.2 Global Retinal Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Retinal Biologics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Retinal Biologics Market Concentration Ratio
3.4.1 Global Retinal Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Biologics Revenue in 2022
3.5 Global Key Players of Retinal Biologics Head office and Area Served
3.6 Global Key Players of Retinal Biologics, Product and Application
3.7 Global Key Players of Retinal Biologics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Retinal Biologics Breakdown Data by Type
4.1 Global Retinal Biologics Historic Market Size by Type (2018-2023)
4.2 Global Retinal Biologics Forecasted Market Size by Type (2024-2033)
5 Retinal Biologics Breakdown Data by Application
5.1 Global Retinal Biologics Historic Market Size by Application (2018-2023)
5.2 Global Retinal Biologics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Retinal Biologics Market Size (2018-2033)
6.2 North America Retinal Biologics Market Size by Type
6.2.1 North America Retinal Biologics Market Size by Type (2018-2023)
6.2.2 North America Retinal Biologics Market Size by Type (2024-2033)
6.2.3 North America Retinal Biologics Market Share by Type (2018-2033)
6.3 North America Retinal Biologics Market Size by Application
6.3.1 North America Retinal Biologics Market Size by Application (2018-2023)
6.3.2 North America Retinal Biologics Market Size by Application (2024-2033)
6.3.3 North America Retinal Biologics Market Share by Application (2018-2033)
6.4 North America Retinal Biologics Market Size by Country
6.4.1 North America Retinal Biologics Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Retinal Biologics Market Size by Country (2018-2023)
6.4.3 North America Retinal Biologics Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Retinal Biologics Market Size (2018-2033)
7.2 Europe Retinal Biologics Market Size by Type
7.2.1 Europe Retinal Biologics Market Size by Type (2018-2023)
7.2.2 Europe Retinal Biologics Market Size by Type (2024-2033)
7.2.3 Europe Retinal Biologics Market Share by Type (2018-2033)
7.3 Europe Retinal Biologics Market Size by Application
7.3.1 Europe Retinal Biologics Market Size by Application (2018-2023)
7.3.2 Europe Retinal Biologics Market Size by Application (2024-2033)
7.3.3 Europe Retinal Biologics Market Share by Application (2018-2033)
7.4 Europe Retinal Biologics Market Size by Country
7.4.1 Europe Retinal Biologics Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Retinal Biologics Market Size by Country (2018-2023)
7.4.3 Europe Retinal Biologics Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Retinal Biologics Market Size (2018-2033)
8.2 China Retinal Biologics Market Size by Type
8.2.1 China Retinal Biologics Market Size by Type (2018-2023)
8.2.2 China Retinal Biologics Market Size by Type (2024-2033)
8.2.3 China Retinal Biologics Market Share by Type (2018-2033)
8.3 China Retinal Biologics Market Size by Application
8.3.1 China Retinal Biologics Market Size by Application (2018-2023)
8.3.2 China Retinal Biologics Market Size by Application (2024-2033)
8.3.3 China Retinal Biologics Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Retinal Biologics Market Size (2018-2033)
9.2 Asia Retinal Biologics Market Size by Type
9.2.1 Asia Retinal Biologics Market Size by Type (2018-2023)
9.2.2 Asia Retinal Biologics Market Size by Type (2024-2033)
9.2.3 Asia Retinal Biologics Market Share by Type (2018-2033)
9.3 Asia Retinal Biologics Market Size by Application
9.3.1 Asia Retinal Biologics Market Size by Application (2018-2023)
9.3.2 Asia Retinal Biologics Market Size by Application (2024-2033)
9.3.3 Asia Retinal Biologics Market Share by Application (2018-2033)
9.4 Asia Retinal Biologics Market Size by Region
9.4.1 Asia Retinal Biologics Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Retinal Biologics Market Size by Region (2018-2023)
9.4.3 Asia Retinal Biologics Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Retinal Biologics Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Retinal Biologics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Retinal Biologics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Retinal Biologics Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Retinal Biologics Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Retinal Biologics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Retinal Biologics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Retinal Biologics Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Retinal Biologics Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Retinal Biologics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Retinal Biologics Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Retinal Biologics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Retinal Biologics Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Spark Therapeutics, Inc
11.1.1 Spark Therapeutics, Inc Company Details
11.1.2 Spark Therapeutics, Inc Business Overview
11.1.3 Spark Therapeutics, Inc Retinal Biologics Introduction
11.1.4 Spark Therapeutics, Inc Revenue in Retinal Biologics Business (2018-2023)
11.1.5 Spark Therapeutics, Inc Recent Developments
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Details
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in Retinal Biologics Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Ltd Recent Developments
11.3 Regeneron Pharmaceuticals, Inc
11.3.1 Regeneron Pharmaceuticals, Inc Company Details
11.3.2 Regeneron Pharmaceuticals, Inc Business Overview
11.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Introduction
11.3.4 Regeneron Pharmaceuticals, Inc Revenue in Retinal Biologics Business (2018-2023)
11.3.5 Regeneron Pharmaceuticals, Inc Recent Developments
11.4 AbbVie Inc
11.4.1 AbbVie Inc Company Details
11.4.2 AbbVie Inc Business Overview
11.4.3 AbbVie Inc Retinal Biologics Introduction
11.4.4 AbbVie Inc Revenue in Retinal Biologics Business (2018-2023)
11.4.5 AbbVie Inc Recent Developments
11.5 Johnson & Johnson Services, Inc
11.5.1 Johnson & Johnson Services, Inc Company Details
11.5.2 Johnson & Johnson Services, Inc Business Overview
11.5.3 Johnson & Johnson Services, Inc Retinal Biologics Introduction
11.5.4 Johnson & Johnson Services, Inc Revenue in Retinal Biologics Business (2018-2023)
11.5.5 Johnson & Johnson Services, Inc Recent Developments
11.6 Amgen Inc
11.6.1 Amgen Inc Company Details
11.6.2 Amgen Inc Business Overview
11.6.3 Amgen Inc Retinal Biologics Introduction
11.6.4 Amgen Inc Revenue in Retinal Biologics Business (2018-2023)
11.6.5 Amgen Inc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Retinal Biologics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Macular Degeneration
Table 3. Key Players of Diabetic Retinopathy
Table 4. Key Players of Diabetic Macular Edema
Table 5. Key Players of Uveitis
Table 6. Key Players of Others
Table 7. Global Retinal Biologics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global Retinal Biologics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Retinal Biologics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Retinal Biologics Market Share by Region (2018-2023)
Table 11. Global Retinal Biologics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Retinal Biologics Market Share by Region (2024-2033)
Table 13. Retinal Biologics Market Trends
Table 14. Retinal Biologics Market Drivers
Table 15. Retinal Biologics Market Challenges
Table 16. Retinal Biologics Market Restraints
Table 17. Global Retinal Biologics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Retinal Biologics Revenue Share by Players (2018-2023)
Table 19. Global Top Retinal Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Biologics as of 2022)
Table 20. Global Retinal Biologics Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Retinal Biologics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Retinal Biologics, Headquarters and Area Served
Table 23. Global Key Players of Retinal Biologics, Product and Application
Table 24. Global Key Players of Retinal Biologics, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Retinal Biologics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Retinal Biologics Revenue Market Share by Type (2018-2023)
Table 28. Global Retinal Biologics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Retinal Biologics Revenue Market Share by Type (2024-2033)
Table 30. Global Retinal Biologics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Retinal Biologics Revenue Share by Application (2018-2023)
Table 32. Global Retinal Biologics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Retinal Biologics Revenue Share by Application (2024-2033)
Table 34. North America Retinal Biologics Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Retinal Biologics Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Retinal Biologics Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Retinal Biologics Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Retinal Biologics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Retinal Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Retinal Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Retinal Biologics Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Retinal Biologics Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Retinal Biologics Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Retinal Biologics Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Retinal Biologics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe Retinal Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Retinal Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Retinal Biologics Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Retinal Biologics Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Retinal Biologics Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Retinal Biologics Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Retinal Biologics Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Retinal Biologics Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Retinal Biologics Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Retinal Biologics Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Retinal Biologics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia Retinal Biologics Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Retinal Biologics Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Retinal Biologics Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Retinal Biologics Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Retinal Biologics Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Retinal Biologics Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Retinal Biologics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America Retinal Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Retinal Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 66. Spark Therapeutics, Inc Company Details
Table 67. Spark Therapeutics, Inc Business Overview
Table 68. Spark Therapeutics, Inc Retinal Biologics Product
Table 69. Spark Therapeutics, Inc Revenue in Retinal Biologics Business (2018-2023) & (US$ Million)
Table 70. Spark Therapeutics, Inc Recent Developments
Table 71. F. Hoffmann-La Roche Ltd Company Details
Table 72. F. Hoffmann-La Roche Ltd Business Overview
Table 73. F. Hoffmann-La Roche Ltd Retinal Biologics Product
Table 74. F. Hoffmann-La Roche Ltd Revenue in Retinal Biologics Business (2018-2023) & (US$ Million)
Table 75. F. Hoffmann-La Roche Ltd Recent Developments
Table 76. Regeneron Pharmaceuticals, Inc Company Details
Table 77. Regeneron Pharmaceuticals, Inc Business Overview
Table 78. Regeneron Pharmaceuticals, Inc Retinal Biologics Product
Table 79. Regeneron Pharmaceuticals, Inc Revenue in Retinal Biologics Business (2018-2023) & (US$ Million)
Table 80. Regeneron Pharmaceuticals, Inc Recent Developments
Table 81. AbbVie Inc Company Details
Table 82. AbbVie Inc Business Overview
Table 83. AbbVie Inc Retinal Biologics Product
Table 84. AbbVie Inc Revenue in Retinal Biologics Business (2018-2023) & (US$ Million)
Table 85. AbbVie Inc Recent Developments
Table 86. Johnson & Johnson Services, Inc Company Details
Table 87. Johnson & Johnson Services, Inc Business Overview
Table 88. Johnson & Johnson Services, Inc Retinal Biologics Product
Table 89. Johnson & Johnson Services, Inc Revenue in Retinal Biologics Business (2018-2023) & (US$ Million)
Table 90. Johnson & Johnson Services, Inc Recent Developments
Table 91. Amgen Inc Company Details
Table 92. Amgen Inc Business Overview
Table 93. Amgen Inc Retinal Biologics Product
Table 94. Amgen Inc Revenue in Retinal Biologics Business (2018-2023) & (US$ Million)
Table 95. Amgen Inc Recent Developments
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Retinal Biologics Market Share by Type: 2022 VS 2033
Figure 3. Macular Degeneration Features
Figure 4. Diabetic Retinopathy Features
Figure 5. Diabetic Macular Edema Features
Figure 6. Uveitis Features
Figure 7. Others Features
Figure 8. Global Retinal Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global Retinal Biologics Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Retinal Biologics Report Years Considered
Figure 14. Global Retinal Biologics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Retinal Biologics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Retinal Biologics Market Share by Region: 2022 VS 2033
Figure 17. Global Retinal Biologics Market Share by Players in 2022
Figure 18. Global Top Retinal Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Biologics as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Retinal Biologics Revenue in 2022
Figure 20. North America Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Retinal Biologics Market Share by Type (2018-2033)
Figure 22. North America Retinal Biologics Market Share by Application (2018-2033)
Figure 23. North America Retinal Biologics Market Share by Country (2018-2033)
Figure 24. United States Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Retinal Biologics Market Size YoY (2018-2033) & (US$ Million)
Figure 27. Europe Retinal Biologics Market Share by Type (2018-2033)
Figure 28. Europe Retinal Biologics Market Share by Application (2018-2033)
Figure 29. Europe Retinal Biologics Market Share by Country (2018-2033)
Figure 30. Germany Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. China Retinal Biologics Market Size YoY (2018-2033) & (US$ Million)
Figure 37. China Retinal Biologics Market Share by Type (2018-2033)
Figure 38. China Retinal Biologics Market Share by Application (2018-2033)
Figure 39. Asia Retinal Biologics Market Size YoY (2018-2033) & (US$ Million)
Figure 40. Asia Retinal Biologics Market Share by Type (2018-2033)
Figure 41. Asia Retinal Biologics Market Share by Application (2018-2033)
Figure 42. Asia Retinal Biologics Market Share by Region (2018-2033)
Figure 43. Japan Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. South Korea Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Taiwan Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Retinal Biologics Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Retinal Biologics Market Share by Type (2018-2033)
Figure 51. Middle East, Africa, and Latin America Retinal Biologics Market Share by Application (2018-2033)
Figure 52. Middle East, Africa, and Latin America Retinal Biologics Market Share by Country (2018-2033)
Figure 53. Brazil Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Mexico Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Turkey Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Israel Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GCC Countries Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Spark Therapeutics, Inc Revenue Growth Rate in Retinal Biologics Business (2018-2023)
Figure 60. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Retinal Biologics Business (2018-2023)
Figure 61. Regeneron Pharmaceuticals, Inc Revenue Growth Rate in Retinal Biologics Business (2018-2023)
Figure 62. AbbVie Inc Revenue Growth Rate in Retinal Biologics Business (2018-2023)
Figure 63. Johnson & Johnson Services, Inc Revenue Growth Rate in Retinal Biologics Business (2018-2023)
Figure 64. Amgen Inc Revenue Growth Rate in Retinal Biologics Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries